Severe thyroiditis induced by sintilimab monotherapy in a patient with non-small cell lung cancer: a case report and literature review by Xiaolin Zhao, Xiaoyu Wang, Surui Liu, Pian Cheng, Jinjuan Chen, Jie Liu

Subjects: “…sintilimab…”
Get full text

Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis by Yuxi Ma, Yuting Li, Zhenyu Lin, Jing Wang, Jianli Hu, Hongli Liu, Yali Yang, Junli Liu, Tao Zhang

Subjects: Get full text

Hyperprogression disease induced by Sintilimab combined with Oxaliplatin and S-1 after surgery: a case report and literature review by Yaoqi Li, You Wang, Rui Shen, Weijun Liu, Chenglou Zhu, Chenglou Zhu

Subjects: Get full text

Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined wit... by Chenghao Fu, Chenghao Fu, Haonan Du, Qiang Wang, Weiyou Zhu, Guangli Bian, Zhujuan Zhong, Yuheng Wang, Lei Cao

Subjects: Get full text

Case Report: Successful treatment of triple primary cancers (lung, stomach, and intestine) using sintilimab combined with chemotherapy and targeted therapy by Qi-Qing Zhang, Xin-Xin Luo, Hua Chen, Wei Wang, Yi-Fan Xie, Hong-Li Qiao, Hao-Jun Miao, Zheng-Quan Feng

Subjects: Get full text

Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab... by Chenghao Fu, Chenghao Fu, Haonan Du, Qiang Wang, Weiyou Zhu, Guangli Bian, Zhujuan Zhong, Yuheng Wang, Lei Cao

Subjects: Get full text

Fruquintinib and sintilimab plus SOX as perioperative therapy for locally resectable advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, si... by Xiangyu Meng, Dong Yang, Yuanlin Liu, Chao Wang, Junqiao Yao, Tao Zhang

Subjects: Get full text

Case report: Chemotherapy plus sintilimab for the treatment of gastroesophageal junction hepatoid adenocarcinoma with liver metastasis: a case study with literature review by Genlin Lu, Jiarui Tu, Jinming Tu, Renya Jiang

Subjects: Get full text

Case Report: Multiple cutaneous keratoacanthoma-like lesions in a colorectal cancer patient treated with sintilimab by Shiyi Li, Shiyi Li, Shiyi Li, Xianhui Ye, Xianhui Ye, Xiaofen Li, Xiaofen Li, Yu Yang, Yu Yang

Subjects: “…sintilimab…”
Get full text

A case report: interstitial pneumonia following treatment of gastric cancer with sintilimab in combination with S-1 by Pei Zhu, Qingming Sun, Sheng Xu, Wanhui Dong

Subjects: Get full text

The safety and effectiveness of sintilimab versus camrelizumab, both plus targeted drugs, in advanced hepatocellular carcinoma by Chenglong Zhao, Qiongni Zhu, Xiaoyan Qian, Zhonghua Fu, Wei Zhang, Yaqin Wang

Subjects: “…sintilimab…”
Get full text

Combination therapy of TKIs and ICIs for the treatment of anaplastic thyroid carcinoma by Xi Zhang, Hongzhi Lu, Yuanshi Lv, Hong Gao, Hui Jin

Subjects: Get full text

Sintilimab for the treatment of lung adenocarcinoma-induced immune-related hypophysitis: a case report by Ming-xing Wang, Ai-xin Liu, Qing-ming Sun, Wan-hui Dong

Subjects: “…sintilimab…”
Get full text

Safety and efficacy of sintilimab versus pembrolizumab in the treatment of advanced or recurrent pediatric malignancies: a real-world study in China by Lei Mao, Mengzhen Li, Linnan Wu, Juan Wang, Yi Que, Feifei Sun, Junting Huang, Suying Lu, Zijun Zhen, Jia Zhu, Mengjia Song, Yizhuo Zhang

Subjects: Get full text

Neoadjuvant sintilimab and chemotherapy for resectable esophageal squamous cell carcinoma: a phase II clinical trial by Jincheng Guo, Chengrui Qiao, Jiabin Lu, Shiqing Yang, Boyi Zhang, Dongxia Tang, Hui Pang

Subjects: Get full text

Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study by Lingzhan Meng, Hu Li, Yingjie Ji, Peng Yu, Zizheng Wang, Li Cao, Bin Shi, Yanling Shao, Jin Yan, Yinjie Gao, Zhenyu Zhu

Subjects: Get full text

Matching-adjusted indirect comparison of tislelizumab plus lenvatinib versus sintilimab plus bevacizumab biosimilar as first-line treatment for unresectable hepatocellular carcinom... by Kunyuan Wang, Kunyuan Wang, Chang Liu, Xiaoling Song, Na Zhao, Xin Zheng

Subjects: Get full text

Evaluation of the efficacy and safety of TACE combined with anlotinib and sintilimab in the treatment of patient with CNLC stage ⅡB-ⅢB liver cancer by TONG Gang, HUA Yang, PENG Wei, ZHAO Ju, HU Junwen

Subjects: “…|liver cancer|transcatheter arterial chemoembolization|sintilimab|anlotinib|targeted-immune combination therapy…”
Get full text

Efficacy and safety of perioperative sintilimab plus platinum-based chemotherapy for potentially resectable stage IIIB non-small cell lung cancer (periSCOPE): an open-label, single... by Xiangyang Yu, Chujian Huang, Longde Du, Chunguang Wang, Yikun Yang, Xin Yu, Shengcheng Lin, Chenglin Yang, Hongbo Zhao, Songhua Cai, Zhe Wang, Lixu Wang, Xiaotong Guo, Baihua Zhang, Zhentao Yu, Jie He, Kai Ma

Subjects: Get full text

Stevens–Johnson syndrome induced by Sintilimab: a case report and literature review by Huan Kuang, DongBei Huang, ChuXiang Hu, LiPing Gong, ZiYu Yu, XunJin Zhu, HongRong Lan, Gang Huang

Subjects: Get full text